Universal American: A Healthy Collaboration

Universal American Home
Investor Relations
Stock Quote & Chart
Press Releases
Financial Reports
Quarterly Results
Annual
Meeting/Proxy
Calendar
SEC Filings
Analyst Coverage
Presentations
Audio Archives
Tax Implications of
2016 Dividend
Tax Implications of
2015 Dividend
Tax Implications of
2014 Dividend
Tax Implications of
2013 Dividend
Tax Implications of
2012 Dividend
Tax Implications –
Part D Sale
E-mail Alerts
Request Info

Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
IR ContactsIR Contacts

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Universal American Corp. Reports 2016 Second Quarter Results

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Aug. 4, 2016-- Universal American Corp. (NYSE:UAM) today announced financial results for the quarter ended June 30, 2016.

Recent Developments

  • In June 2016, Universal American issued $115 million principal amount of convertible notes and used the proceeds, together with cash on hand, to repurchase approximately 20.2 million shares of our common stock for an aggregate purchase price of approximately $138 million, or an average price of $6.84 per share;
  • On August 1, 2016, Universal American completed its previously-announced sale of its Total Care Medicaid business; and
  • On August 3, 2016, Universal American completed its previously-announced sale of its Traditional Insurance business.

Results of Second Quarter 2016

Universal American’s reported net income for the second quarter of 2016 was $22.8 million, or $0.27 per share. Adjusted net income for the second quarter of 2016 was $5.0 million, or $0.06 per share, which excludes the following after-tax items:

  • $13.7 million, or $0.17 per share, of income associated with our Management Services Organization (MSO) segment, which includes our Accountable Care Organization (ACO) business;
  • $1.1 million, or $0.01 per share of net realized investment gains;
  • $0.4 million, or less than $0.01 per share, of tax benefits;
  • $4.4 million, or $0.05 per share of income from discontinued operations, including our Traditional Insurance and Total Care Medicaid businesses, which are treated as held for sale, and the APS Healthcare businesses, which were sold in 2015; and
  • $1.8 million, or $0.02 per share of legal and consulting costs related to corporate development activities.

Total revenues for the second quarter of 2016 were approximately $346 million.

Results of Six Months ended June 30, 2016

Universal American’s reported net income for the six months ended June 30, 2016 was $23.0 million, or $0.28 per share. Adjusted net income for the six months ended June 30, 2016 was $12.3 million, or $0.15 per share, which excludes the following after-tax items:

  • $8.2 million, or $0.10 per share, of income associated with our Management Services Organization (MSO) segment, which includes our Accountable Care Organization (ACO) business;
  • $1.6 million, or $0.02 per share, of net realized investment gains;
  • $0.6 million, or less than $0.01 per share, of tax benefits;
  • $3.1 million, or $0.04 per share of income from discontinued operations, including our Traditional Insurance and Total Care Medicaid businesses, which are treated as held for sale, and the APS Healthcare businesses, which were sold in 2015; and
  • $2.8 million, or $0.03 per share, of legal and consulting costs related to corporate development activities.

Total revenues for the first half of 2016 were approximately $695 million.

Management Comments

Richard A. Barasch, Chairman and CEO, commented, “Our core strength and the foundation of our strategy is partnering with primary care physicians to improve health outcomes while reducing costs in the Medicare population. Over the past 15 years, we have built a platform that combines efficient use of data and care management protocols with the critical work of establishing trust with our physician partners. We now have over 350,000 Medicare beneficiaries on this platform in Medicare Advantage, Medicare Shared Savings ACOs and Next Generation ACOs.

“Our Medicare Advantage business is now concentrated in regions where we have a meaningful market position, strong relationships with primary care physicians and the ability to positively impact the quality and cost of healthcare.

“We are building on our successful 15-year history of working closely with our physician partners in the Houston/Beaumont region to improve quality and reduce cost for Medicare beneficiaries. Our second quarter 2016 results demonstrate the ongoing strength of this business.

“In partnership with many of our most experienced Houston doctors, we were awarded a Next Generation ACO beginning in January 2016. This adds approximately 14,000 full-risk Medicare beneficiaries to the 65,500 Medicare beneficiaries we are already serving in our Southeast Texas MA business. We are pleased to report positive current year results from this program.

“In the Northeast, especially upstate New York, we are in the process of converting a fee-for-service market into a more value-based system by introducing pay for performance to primary care physicians. We are encouraged that the Northeast, even factoring out prior period items, has returned to profitability.

“The results from the 2015 program year in our MSSP ACO business showed significant improvement. Ten of our ACOs achieved shared savings in the amount of $39.8 million, a 48% increase over PY2014. The net revenue to UAM is $28.6 million, a 37% increase over PY2014. For the 2016 program year, we have reduced the number of active MSSP ACOs, reduced our operating expenses and have moved our most successful ACOs to 2-sided risk with higher gain sharing. We are encouraged by the progress in cost and quality shown by our physician partners and by the positive regulatory changes in the MSSP program.

“With the completed sales of our Traditional Insurance and Medicaid businesses, we have replenished our cash position after the buyback of two large blocks of UAM stock and can now concentrate fully on our Medicare Advantage and Medicare ACO businesses.”

2016 Membership (as of June 30, 2016)

  • Medicare Advantage:
    • 68,600 members in Texas
    • 45,300 members in upstate New York and Maine
  • Management Services Organization:
    • 14,000 Medicare beneficiaries in our Next Generation ACO in Houston, Texas
    • 60,100 Medicare beneficiaries in 6 ACOs that have selected Track 2 (2-sided risk) in the Medicare Shared Savings Program (MSSP)
    • 165,000 Medicare beneficiaries in 16 ACOs that have selected Track 1 (1-sided risk) in the MSSP
    • Approximately 3,200 physicians and 1,800 associated clinical professionals

Medicare Advantage

 

Three Months Ended

June 30, 2016

      Six Months Ended

June 30, 2016

Financial Performance ($ in millions)

           
   
Premiums(1) $ 342.4 $ 688.5
Net investment income & other income 2.3 5.1
Revenue 344.7 693.6
 
Quality initiatives 5.6 1.6% 11.2 1.6%
Medical benefits 282.9 82.7% 566.0 82.2%
Total benefits 288.5 84.3% 577.2 83.8%
 
Admin expenses 32.9 9.6% 65.6 9.5%
ACA Fee 5.4 10.8
 
Pre-Tax operating income $ 17.9 $ 40.0
 
Reported Recast** Reported Recast**
Texas HMOs Medical Benefit Ratio* 81.6% 82.1% 81.9% 82.9%
Upstate New York/Maine Medical Benefit Ratio** 84.8% 86.3% 83.2% 84.8%

(1) Effective January 1, 2016, we changed the way in which we estimate changes in risk-adjusted premiums receivable from CMS, which resulted in the accelerated recognition of additional current year premium revenue of $9.1 million and $18.8 million for the three months and six months ended June 30, 2016, respectively. See our Form 10-Q for the period ending June 30, 2016 for additional discussion.

* Excluding quality initiatives.

** Recast excludes the impact of prior period items.

Medicare Advantage pre-tax income for the three month period ended June 30, 2016 was $17.9 million, including $4.2 million of net favorable prior period items. Medicare Advantage pre-tax operating income during the first half of 2016 was $40.0 million, including $11.2 million of net favorable prior period items. Our administrative expense ratio was 9.6% for second quarter 2016 and 9.5% for the six months ended June 30, 2016.

Texan Plus®, a 4-Star plan, is the largest Medicare HMO in Southeast Texas. Texan Plus® now has 65,300 members and has achieved 9% compounded membership growth over the past four years. Virtually all of our members in this plan are in value-based payment arrangements. For the second quarter of 2016, the reported Medical Benefit Ratio (MBR) in our Texas HMOs was 81.6%. Excluding positive prior period items, the MBR was 82.1% for the second quarter. For the six months ended June 30, 2016, the reported MBR in our Texas HMOs was 81.9% and 82.9% excluding prior period items.

Our Northeast markets experienced a 52% increase in membership since 2014 year-end and now have 45,300 members with a large concentration in upstate New York. For the second quarter of 2016, the reported MBR in our Northeast markets was 84.8%. Excluding positive prior period items, the MBR was 86.3% for the second quarter. For the six months ended June 30, 2016, the reported MBR in our Northeast markets was 83.2% and 84.8% excluding prior period items.

Management Services Organization (MSO)

Financial Performance ($ in millions)

Three Months Ended

June 30,

Six Months Ended

June 30,

2016

 

2015

 

2016

 

2015

Shared Savings Revenue:
Gross Shared Savings $ 41.0 $ 26.9 $ 41.0 $ 26.9
ACO Partner Share   (11.2)   (6.0)   (10.5)   (6.0)
Net Shared Savings Revenue 29.8 20.9 30.5 20.9
Operating expenses   8.7   9.3   17.8   21.0
Segment income (loss) before income taxes $ 21.1 $ 11.6 $ 12.7 $ (0.1)
 

The MSO segment includes our ACO business, which collaborates with primary care physicians and other healthcare professionals to operate ACOs under the Medicare Shared Savings Program (MSSP) and the Next Generation ACO model in Houston, Texas. At June 30, 2016, we had 22 MSSP ACOs and one Next Generation ACO with approximately 239,100 assigned Medicare fee-for-service beneficiaries.

On July 29, 2016, the Centers for Medicare & Medicaid Services (CMS) informed us that our Medicare Shared Savings Program (MSSP) ACOs generated $97 million in gross savings for program year 2015. This compares to $80 million in gross savings for program year 2014. Ten of our ACO’s qualified for shared savings payments in program year 2015, compared to nine in program year 2014, and will receive gross shared savings payments of $39.8 million, compared to $26.9 million in program year 2014. Our share of these payments, after payments to our physician partners increased to $28.6 million from $20.9 million in the prior year, and is reflected in equity in earnings of unconsolidated subsidiaries in our consolidated statements of operations. We expect to receive these payments during the third quarter of 2016.

Effective January 1, 2016, in partnership with a high-performing group of our Houston physicians, our Houston-based ACO was selected by CMS to become a Next Generation ACO, a value-based payment model that encourages providers to assume greater risk and reward in coordinating the healthcare of Medicare Fee-For-Service (FFS) beneficiaries. The Next Generation ACO adds approximately 14,000 beneficiaries in a full-risk program that allows us to use many of the same techniques, including creating preferred networks and negotiating discounts that have worked well for our Medicare Advantage plan in Houston. Based on information from CMS, we reported positive current year results from this program.

Our MSO segment generated pre-tax income of $21.1 million for the quarter ended June 30, 2016 compared to $11.6 million in the same period of 2015. Operating expenses for the quarter were $8.7 million compared to $9.3 million for the quarter ended June 30, 2015, reflecting fewer active ACOs.

Corporate & Other

  Three Months Ended

June 30,

 

Six Months Ended

June 30,

Financial Performance ($ in millions)   2016   2015

2016

  2015
       
Revenue $ 0.4 $ 2.6 $ 0.6 $ 3.5
 
Pre-tax operating loss $ (9.5) $ (11.4) $ (18.3) $ (22.0)
 

Our Corporate & Other segment reflects the activities of our parent holding company, debt service and other ancillary operations including support services provided to the buyers of the APS Healthcare businesses through Transition Services Agreements which ended in 2015.

Corporate expenses for the three and six months ended June 30, 2016 included $2.3 million and $4.3 million of legal and consulting costs related to corporate development activities. Dividends on our Preferred Stock were $0.8 million and $1.6 million for the three and six month periods ending June 30, 2016, respectively.

Convertible Senior Notes Offering

On June 27, 2016, the Company completed a private offering of $115 million principal amount of Convertible Senior Notes due 2021. The notes are unsecured, senior obligations of Universal American bearing interest at 4.00% per annum, payable in cash semi-annually in arrears, beginning on December 15, 2016. The notes are convertible, subject to certain conditions, into cash, shares of Universal American’s common stock or a combination of cash and shares of Universal American’s common stock, at Universal American’s option. The initial conversion rate per $1,000 principal amount of notes is equivalent to 105.8890 shares of common stock, which is equivalent to a conversion price of approximately $9.44 per share, subject to adjustment in certain circumstances. After accounting for the equity component of the notes, the carrying value on the Balance Sheet at June 30, 2016 was $90.3 million.

Universal American used the net proceeds from the offering of the notes, together with cash on hand, to repurchase: (i) 18.1 million shares of Universal American common stock from existing large shareholders at a purchase price of $6.80 per share, for an aggregate purchase price of approximately $123 million, and (ii) 2.1 million shares of its common stock in connection with the offering for an aggregate purchase price of approximately $15.1 million.

As of June 30, 2016, there were 65.1 million common shares outstanding.

Divestitures

Total Care Medicaid Plan – On August 1, 2016, the Company completed the sale of the Total Care health plan to Molina Healthcare, Inc. The purchase price paid was approximately $38 million which is subject to post-closing balance sheet adjustments.

Traditional Insurance – On August 3, 2016, the Company completed the sale of its Traditional Insurance business to Nassau Reinsurance Group. The purchase price paid was approximately $30.5 million which is subject to post-closing price adjustments.

Discontinued Operations

Discontinued Operations includes our Traditional Insurance and Total Care Medicaid businesses, which are treated as held for sale, and the APS businesses, which were sold in 2015.

The following table presents the components comprising the income (loss) from discontinued operations before income taxes:

Financial Performance ($ in millions)

    Three Months Ended

June 30,

  Six Months Ended

June 30,

2016

 

2015

2016

 

2015

Total Care Medicaid:
Operating results $ (2.3) $ (1.6) $ (4.3) $ (1.4)
 
Traditional Insurance:
Operating results $ 6.5 $ 4.3 $ 9.2 $ 5.6
Realized gains - 0.1 0.2 0.1
Fair value adjustment   2.1   -   -   -
Total Traditional   8.6   4.4   9.3   5.7
 
APS Healthcare:
Operating results $ (1.1) $ (8.5) $ (1.7) $ (4.2)
Gain (loss) on Sale 6.5 (18.3) 7.7 (18.7)
Total APS Healthcare   5.4   (26.8)   6.0   (22.9)
 
Segment income (loss) before income taxes $ 11.7 $ (24.0) $ 11.1 $ (18.6)
 

Investment Portfolio

As of June 30, 2016, Universal American had $290.1 million of cash and invested assets as follows:

  • 21% is invested in U.S. Government and agency securities;
  • The average credit quality of the investment portfolio is A+; and
  • Less than 1% of the investment portfolio is non-investment grade.

A complete listing of our fixed income investment portfolio as of June 30, 2016 is available for review in the financial supplement located in the Investors – Financial Reports section of our website, www.UniversalAmerican.com.

Balance Sheet and Liquidity

As of June 30, 2016, Universal American’s Balance Sheet had the following characteristics:

  • Unregulated cash and investments of $29.8 million, or $98.3 million Proforma for the two recently completed divestitures;
  • Total cash and investments were $290.1 million and total assets were $1.7 billion, including $1.2 billion in assets of discontinued operations;
  • Total policyholder liabilities were $83.0 million and total liabilities were $1.5 billion, including $1.1 billion in liabilities of discontinued operations;
  • Stockholders’ equity was $287.8 million and book value was $4.41 per diluted common share;
  • Tangible book value per diluted common share (excluding accumulated other comprehensive income, goodwill, amortizing intangibles and deferred acquisition costs) was $3.14;
  • $115 million of convertible senior notes with a carrying value of $90.3 million which bear cash interest of 4.0% per annum and an annual effective interest rate of 8.5%; and
  • $40.0 million of mandatorily redeemable preferred stock, reported as a liability, with an annual dividend rate of 8.5%.

As of June 30, 2016, the ratio of debt to total capital, excluding the effect of accumulated other comprehensive income and including Universal American’s mandatorily redeemable preferred stock and convertible note principal balances as debt, was 37.6%.

Conference Call

Universal American will host a conference call at 8:30 a.m. Eastern Time on Thursday, August 4, 2016 to discuss financial results and other corporate developments. Interested parties may participate in the call by dialing (661) 378-9883. Please call in 10 minutes before the scheduled time and mention conference ID: 56394348. This conference call will also be available live over the Internet and can be accessed at Universal American’s website at www.UniversalAmerican.com, and clicking on the “Investors” link in the upper right. To listen to the live call on the website, please go to the website at least 15 minutes early to download and install any necessary audio software. A replay of the call will be available on the investor relations section of the Company’s website for approximately two weeks following the call.

Prior to the conference call, Universal American will make available on its website a 2nd Quarter 2016 Investor Presentation and supplemental financial data in connection with its quarterly earnings release. You can access the 2nd Quarter 2016 Investor Presentation and supplemental financial data at www.UniversalAmerican.com in the “Investors” section under the “Presentations” and “Financial Reports” sections.

About Universal American Corp.

Universal American (NYSE: UAM), through our family of healthcare companies, provides health benefits to people covered by Medicare. We are dedicated to working collaboratively with healthcare professionals, especially primary care physicians, in order to improve the health and well-being of those we serve and reduce healthcare costs. For more information on Universal American, please visit our website at www.UniversalAmerican.com.

Forward Looking Statements

This news release and oral statements made from time to time by our executive officers may contain "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. Such statements that are not historical facts are hereby identified as forward-looking statements and intended to be covered by the safe harbor provisions of the PSLRA and can be identified by the use of the words "believe," "expect," "predict," "project," "potential," "estimate," "anticipate," "should," "intend," "may," "will," and similar expressions or variations of such words, or by discussion of future financial results and events, strategy or risks and uncertainties, trends and conditions in our business and competitive strengths, all of which involve risks and uncertainties.

Where, in any forward-looking statement, we or our management expresses an expectation or belief as to future results or actions, there can be no assurance that the statement of expectation or belief will result or be achieved or accomplished. Our actual results may differ materially from our expectations, plans or projections. We warn you that forward-looking statements are only predictions and estimates, which are inherently subject to risks, trends and uncertainties, many of which are beyond our ability to control or predict with accuracy and some of which we might not even anticipate. We give no assurance that we will achieve our expectations and we do not assume responsibility for the accuracy and completeness of the forward-looking statements. Future events and actual results, financial and otherwise, may differ materially from the results discussed in the forward-looking statements as a result of many factors, including the risk factors described in the risk factor section of our SEC reports.

A summary of the information set forth in the "Risk Factors" section of our SEC reports and other risks includes, but is not limited to the following: the impact of the Centers for Medicare and Medicaid Services’ (“CMS”) final Medicare Advantage reimbursement rates for calendar year 2017 could have a material adverse effect on Universal American’s MA business; we are subject to extensive government regulation and the potential that CMS and/or other regulators could impose significant fines, penalties or operating restrictions on Universal American, including with respect to False Claims Act matters or Risk Adjustment Data Validation (“RADV”) audits; the results of the 2016 presidential election, the Affordable Care Act and subsequent rules promulgated by CMS could have a material adverse effect on our opportunities for growth and our financial results; we are investing significant capital and management attention in new and unproven business opportunities, including our Accountable Care Organizations (“ACOs”), where we will begin to take two-sided risk in 2016, that may not be profitable; we may experience higher than expected medical loss ratios or lower revenues, especially with our new members in our Northeast markets, which could materially adversely affect our results of operations; If we are unable to develop and maintain satisfactory relationships with the providers of care to our members and ACO beneficiaries, our business and overall profitability could be materially adversely affected; if we fail to design and price our products properly and competitively or if the premiums and fees we charge are insufficient to cover the cost of health care services delivered to our members, our profitability may be materially adversely affected; our significant shareholders may have interests that are different than other shareholders and may sell or distribute their stock which could cause the price of our stock to decline; changes in governmental regulation or legislative reform could increase our costs of doing business and adversely affect our profitability; reductions in funding for Medicare programs could materially reduce our profitability; failure to reduce our operating and corporate costs could have a material adverse effect on our financial position, results of operations and cash flows; we may not be able to maintain or improve our CMS Star ratings which may cause certain of our plans to receive less bonuses or rebates than our competitors; changes in governmental regulation or legislative reform, including the impact of Sequestration, could reduce our revenues, increase our costs of doing business and adversely affect our profitability; a substantial portion of our revenues are tied to our Medicare businesses and regulated by CMS and if our government contracts are not renewed or are terminated, our business could be substantially impaired; any failure by us to manage our operations or to successfully complete or integrate acquisitions, dispositions and other significant transactions could harm our financial results, business and prospects; we could be subject to a cyber-attack or similar network breach that could damage our reputation and have a material adverse effect. Other unknown or unpredictable factors could also have material adverse effects on future results, performance or achievements of Universal American.

All forward-looking statements included in this release are based upon information available to Universal American as of the date of the release, and we assume no obligation to update or revise any such forward-looking statements.

(Tables to follow)

 

UNIVERSAL AMERICAN CORP. AND SUBSIDIARIES

SELECTED CONSOLIDATED FINANCIAL DATA

In millions, except per share amounts

(Unaudited)

   
Three Months Ended

June 30,

Six Months Ended

June 30,

Continuing operations

2016

2015

2016

2015

 
 
Net premiums $ 342.4 $ 314.8 $ 688.5 $ 620.1
Net investment income 2.1 2.6 4.4 5.6
Fee and other income 0.5 2.1 1.0 2.4
Net realized gains 1.1 3.4 1.5 3.9
Total revenues 346.1 322.9 695.4 632.0
 
Claims and other benefits 288.5 271.1 577.2 534.2
Amortization of intangible assets 0.2 0.5 0.5 1.0
Affordable Care Act fee 5.4 6.4 10.8 12.7
Commissions and general expenses, net of allowances 46.3 45.8 90.7 89.9
Total benefits and expenses 340.4 323.9 679.2 637.8
 
Income (loss) before equity in earnings of unconsolidated subsidiaries 5.7 (0.9) 16.2 (5.8)
 
Equity in earnings of unconsolidated subsidiaries 24.9 13.7 19.7 6.3

Income from continuing operations before income taxes

30.6 12.8 35.9 0.5
Provision for (benefit from) income taxes 12.2 6.9 16.0 (5.4)
 
Income from continuing operations 18.4 5.9 19.9 5.9
 

Discontinued operations

 

Income (loss) from discontinued operations before income taxes

11.7 (24.0) 11.1 (18.6)

Income tax provision (benefit)(1)

7.3 (10.7) 8.0 (7.5)

Income (loss) from discontinued operations

4.4 (13.3) 3.1 (11.1)
 
Net income (loss) $ 22.8 $ (7.4) $ 23.0 $ (5.2)

 

Per Share Data (Diluted)

Continuing operations $ 0.22 $ 0.07 $ 0.24 $ 0.07
Discontinued operations 0.05 (0.16) 0.04 (0.13)
Net income (loss) $ 0.27 $ (0.09) $ 0.28 $ (0.06)
 
Diluted weighted average shares outstanding 83.0 83.8 83.4 83.6
 
 

UNIVERSAL AMERICAN CORP. AND SUBSIDIARIES

SELECTED CONSOLIDATED FINANCIAL DATA

In millions, except per share amounts

(Unaudited)

 
  Three Months Ended

June 30,

      Six Months Ended

June 30,

Income (loss) before income taxes by Segment

2016

2015

2016

2015

 
Medicare Advantage $ 17.9 $ 9.2 $ 40.0 $ 18.7
MSO 21.1 11.6 12.7 (0.1)
Corporate & Other (9.5) (11.4) (18.3) (22.0)
Realized gains 1.1 3.4 1.5 3.9
 
Income from continuing operations before income taxes $ 30.6 $ 12.8 $ 35.9 $ 0.5
 
 
BALANCE SHEET DATA      

June 30, 2016

Total cash and investments $ 290.1
Total assets $ 1,744.7
Total policyholder related liabilities $ 83.0
Total reinsurance recoverable (ceded policyholder liabilities) $ 1.2
Convertible senior notes due 2021* - principal balance $ 115.0
Mandatorily redeemable preferred shares* - principal balance $ 40.0
Total stockholders' equity $ 287.8
Diluted book value per common share $ 4.41
Diluted common shares outstanding at balance sheet date 65.3
 

Non-GAAP Financial Measures *

Total stockholders’ equity (excluding AOCI) * $ 277.7
Diluted book value per common share (excluding AOCI) * (2) $ 4.26
Diluted tangible book value per common share (excluding AOCI) ** (3) $ 3.14
Debt to total capital ratio (excluding AOCI) * (4) 37.6%
 
         
Three Months Ended

June 30,

Six Months Ended

June 30,

2016

 

2015

2016

 

2015

 
Adjusted net income(5) $ 5.0 $ 0.1 $ 12.3 $ 1.8
Adjusted net income per share (diluted) $ 0.06 $ 0.00 $ 0.15 $ 0.02
 

* Excludes unamortized debt issue costs of $4.1 million on the convertible senior notes and $0.2 million on the mandatorily redeemable preferred shares.

** Non-GAAP Financial Measures - See supplemental tables on the following pages of this release for a reconciliation of these items to financial measures calculated under U.S. generally accepted accounting principles (GAAP).

(1) For the quarter ended June 30, 2016, our effective tax rate on continuing operations was 40%, resulting in an income tax provision of $12.2 million. For the same period in 2015, our effective tax rate on continuing operations was 53.9%, resulting in an income tax provision of $6.9 million. The high effective tax rate in both periods was driven by permanent differences, primarily the non-deductible ACA Fee and non-deductible interest expense on our preferred stock. State income taxes also contributed to the variance in the effective tax rates. For the six months ended June 30, 2016, our effective tax rate on continuing operations was 44.5%, resulting in an income tax provision of $16.0 million. For the same period in 2015, our effective tax rate on continuing operations exceeded 100%, resulting in an income tax benefit of $5.4 million. The high effective tax rate in the first half of 2016 was driven by permanent differences, primarily the non-deductible ACA Fee and non-deductible interest expense on our preferred stock. State income taxes also contributed to the variance in the effective tax rates. For the six months ended June 30, 2015, the tax benefit included $5.4 million in foreign tax credit carryforwards created in connection with the February 2015 sale of APS Puerto Rico. Excluding the foreign tax credit carryforwards, the effective tax rate was 1.5%, driven by permanent items, including the non-deductible ACA Fee and non-deductible interest expense. State and foreign income taxes also contributed to the variance in the effective tax rate.

(2) Diluted book value per common share (excluding AOCI) represents Total Stockholders’ Equity, excluding accumulated other comprehensive income (“AOCI”), plus assumed proceeds from the exercise of vested, in-the-money options, divided by the total shares outstanding plus the shares assumed issued from the exercise of vested, in-the-money options.

(3) Tangible book value per common share represents Total Stockholders’ Equity, excluding AOCI and intangible assets plus assumed proceeds from the exercise of vested, in-the-money options, divided by the total shares outstanding plus the shares assumed issued from the exercise of vested, in-the-money options.

(4) The Debt to Total Capital Ratio (excluding AOCI) is calculated as the ratio of the principal balance of the Convertible senior notes and Mandatorily redeemable preferred shares to the sum of Stockholders’ Equity (excluding AOCI) plus the principal balance of the Convertible senior notes and Mandatorily redeemable preferred shares reported as liabilities.

(5) Adjusted net income is calculated as net income (loss) excluding the following items on after-tax basis: ACO results, net realized gains, tax benefit, discontinued operations and development-related legal and consulting costs.

 

UNIVERSAL AMERICAN CORP. AND SUBSIDIARIES

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP FINANCIAL MEASURES

In millions, except per share amounts

(Unaudited)

 

Universal American uses both GAAP and non-GAAP financial measures to evaluate the Company’s performance for the periods presented in this press release. You should not consider non-GAAP measures to be an alternative to measurements required by GAAP. Because Universal American’s calculation of these measures may differ from the calculation of similar measures used by other companies, investors should be careful when comparing Universal American’s non-GAAP financial measures to those of other companies. We have not included a reconciliation of projected earnings per diluted share because projections for some components of this reconciliation are not possible to forecast at this time. The key non-GAAP measures presented in our press release, including reconciliation to GAAP measures, are set forth below.

 

Adjusted Net Income ($ in millions, except per share amounts)

 
Three Months Ended

June 30,

      Six Months Ended

June 30,

2016

2015

2016

2015

 
Net income (loss)       $ 22.8 $ (7.4) $ 23.0 $ (5.2)
ACO results, after-tax (13.7) (4.9) (8.2) 0.4
Net realized gains, after-tax (1.1) (2.2) (1.6) (2.6)
Tax benefit (0.4) (0.2) (0.6) (5.5)
Discontinued operations, after-tax (4.4) 13.3 (3.1) 11.2
Legal and consulting costs, after-tax 1.8 1.5 2.8 3.5
Adjusted net income $ 5.0 $ 0.1 $ 12.3 $ 1.8
 
Per share (diluted)
Net income (loss) $ 0.27 $ (0.09) $ 0.28 $ (0.06)
ACO results, after-tax (0.17) (0.06) (0.10) 0.01
Net realized gains, after-tax (0.01) (0.03) (0.02) (0.03)
Tax benefit - - - (0.07)
Discontinued operations, after-tax (0.05) 0.16 (0.04) 0.13
Legal and consulting costs, after-tax 0.02 0.02 0.03 0.04
Adjusted net income $ 0.06 $ 0.00 $ 0.15 $ 0.02
 

Universal American uses adjusted net income, calculated as net income excluding ACO results after-tax, net realized gains after-tax, tax benefit, discontinued operations and development-related legal and consulting costs after-tax as a basis for evaluating operating results. Although the excluded items may recur, we believe that the excluded items do not relate to the performance of Universal American’s core business operations and that adjusted net income provides a more useful comparison of our business performance from period to period.

     

Total Stockholders’ Equity (excluding AOCI)

June 30,

2016

December 31,

2015

Total stockholders’ equity $ 287.8 $ 382.4
Less: Accumulated other comprehensive income (10.1) (2.7)
 
Total stockholders’ equity (excluding AOCI) $ 277.7 $ 379.7
 
 

UNIVERSAL AMERICAN CORP. AND SUBSIDIARIES

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP FINANCIAL MEASURES

In millions, except per share amounts

(Unaudited)

 

Universal American uses total stockholders’ equity (excluding AOCI), as a basis for evaluating growth in equity on both an absolute dollar basis and on a per share basis, as well as in evaluating the ratio of debt to total capitalization. We believe that fluctuations in stockholders’ equity that arise from changes in unrealized appreciation or depreciation on investments, as well as changes in the other components of accumulated other comprehensive income or loss, do not relate to the performance of Universal American’s core business operations.

       
Diluted Book Value per Common Share June 30,

2016

December 31,

2015

Total stockholders’ equity $ 287.8 $ 382.4
Proceeds from assumed exercises of vested options - -
$ 287.8 $ 382.4
Diluted common shares outstanding 65.3 84.9
 
Diluted book value per common share $ 4.41 $ 4.51
 
Total stockholders’ equity (excluding AOCI) $ 277.7 $ 379.7
Proceeds from assumed exercises of vested options - -
$ 277.7 $ 379.7
Diluted common shares outstanding 65.3 84.9
 
Diluted book value per common share (excluding AOCI) $ 4.26 $ 4.47
 

As noted above, Universal American uses total stockholders’ equity (excluding AOCI), as a basis for evaluating growth in equity on a per share basis. We believe that fluctuations in stockholders’ equity that arise from changes in unrealized appreciation or depreciation on investments, as well as changes in the other components of accumulated other comprehensive income, do not relate to the performance of Universal American’s core business operations.

         

Tangible Book Value per Common Share

June 30,

2016

December 31,

2015

Total stockholders’ equity (excluding AOCI) $ 277.7 $ 379.7
Less: intangible assets (1) (72.7) (73.1)
Proceeds from assumed exercises of vested options - -
  Tangible Book Value $ 205.0 $ 306.6
 
Diluted common shares outstanding 65.3 84.9
 
Tangible book value per common share $ 3.14 $ 3.61
 

Universal American uses tangible book value per common share as a basis for evaluating the value of the Company’s tangible net assets.

(1) Intangible assets include the following at June 30, 2016 and December 31, 2015, respectively: goodwill ($68.4 million) and amortizing intangible assets, net of taxes ($4.3 million and $4.7 million).

 

UNIVERSAL AMERICAN CORP. AND SUBSIDIARIES

SUPPLEMENTAL FINANCIAL INFORMATION

NON-GAAP FINANCIAL MEASURES

In millions, except per share amounts

(Unaudited)

 
Debt to Total Capital Ratio   June 30,

2016

  December 31,

2015

Convertible senior notes – principal balance $ 115.0 $ -
Mandatorily redeemable preferred shares – principal balance 40.0 40.0
Total outstanding debt $ 155.0 $ 40.0
 
Total stockholders’ equity(1) $ 287.8 $ 382.4
Convertible senior notes – principal balance reported as liability (1) 94.4 -
Mandatorily redeemable preferred shares – principal balance 40.0 40.0
Total capital $ 422.2 $ 422.4
 
Debt to total capital ratio 36.7% 9.5%
Total stockholders’ equity (excluding AOCI) (1) $ 277.7 $ 379.7
Convertible senior notes – principal balance reported as liability (1) 94.4 -
Mandatorily redeemable preferred shares 40.0 40.0
Total capital $ 412.1 $ 419.7
 
Debt to total capital ratio (excluding AOCI) 37.6% 9.5%

(1) The principal balance of the convertible senior notes has been allocated between its liability and equity components, as required under GAAP. At June 30,
2016, $94.4 million was recorded as a liability and $20.6 million was recorded in equity, as additional paid-in capital.

As noted above, Universal American uses total stockholders’ equity (excluding AOCI), as a basis for evaluating the ratio of debt to total capital. We believe that fluctuations in stockholders’ equity that arise from changes in unrealized appreciation or depreciation on investments, as well as changes in the other components of accumulated other comprehensive income, do not relate to the performance of Universal American’s core business operations.

Source: Universal American Corp.

The Equity Group Inc.
Adam C. Thackery, 914-597-2939
Chief Financial Officer
or
Investor Relations Counsel:
The Equity Group Inc.
Fred Buonocore, 212-836-9607
or
Linda Latman, 212-836-9609
www.theequitygroup.com



© 2002-2008 Universal American